| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
ABPM in Clinical Research Trials
|
Satin, Lawrence
|
|
|
45 |
5 |
p. 568
|
article
|
| 2 |
ABPM Part of FDA Reviews
|
Stockbridge, Norman
|
|
|
45 |
5 |
p. 567
|
article
|
| 3 |
Benefit/Risk Estimates in Clinical Trials
|
Shamoo, Adil E.
|
|
|
45 |
5 |
p. 669-685
|
article
|
| 4 |
Consistency of Treatment Effect across Regions in Multiregional Clinical Trials, Part 1: Design Considerations
|
Chen, Joshua
|
|
|
45 |
5 |
p. 595-602
|
article
|
| 5 |
Consistency of Treatment Effect across Regions in Multiregional Clinical Trials, Part 2: Monitoring, Reporting, and Interpretation
|
Gallo, Paul
|
|
|
45 |
5 |
p. 603-608
|
article
|
| 6 |
Decision Making for a Companion Diagnostic in an Oncology Clinical Development Program
|
Kaiser, Lee
|
|
|
45 |
5 |
p. 645-655
|
article
|
| 7 |
Editor’s Commentary: Letters to the Editor, a New Publishing Partner, and Benefit-Risk Estimation
|
Turner, J. Rick
|
|
|
45 |
5 |
p. 559-564
|
article
|
| 8 |
Establishing a Complete Drug Information Triad: Academic, Industry, and Hospital Training
|
Tadrous, Mina
|
|
|
45 |
5 |
p. 641-644
|
article
|
| 9 |
Impact of Different Regulatory Requirements for Trial Endpoints in Multiregional Clinical Trials
|
Girman, Cynthia J.
|
|
|
45 |
5 |
p. 587-594
|
article
|
| 10 |
Japanese Guideline on Global Clinical Trials: Statistical Implications and Alternative Criteria for Assessing Consistency
|
Carroll, Kevin J.
|
|
|
45 |
5 |
p. 657-667
|
article
|
| 11 |
Multiregional Clinical Trials: An Introduction from an Industry Perspective
|
Binkowitz, Bruce
|
|
|
45 |
5 |
p. 569-573
|
article
|
| 12 |
Points to Consider in Defining Region for a Multiregional Clinical Trial: Defining Region Work Stream in PhRMA MRCT Key Issue Team
|
Tanaka, Yoko
|
|
|
45 |
5 |
p. 575-585
|
article
|
| 13 |
Program Chair Reflects upon DIA 2011
|
Getz, Kenneth A.
|
|
|
45 |
5 |
p. 565-566
|
article
|
| 14 |
Reply to Dr Stockbridge
|
O’Brien, Eoin
|
|
|
45 |
5 |
p. 567-568
|
article
|
| 15 |
Reporting of Adverse Drug Reactions by Community Pharmacists: A Qualitative Study in Quebec
|
Rouleau, Benoît
|
|
|
45 |
5 |
p. 627-639
|
article
|
| 16 |
Results of a Survey of PhRMA Member Companies on Practices Associated with Multiregional Clinical Trials
|
Scott, Nick
|
|
|
45 |
5 |
p. 609-617
|
article
|
| 17 |
Technical Requirements for Biopharmaceutics Classification System-Based Biowaiver in China
|
Ning, Zhang
|
|
|
45 |
5 |
p. 619-625
|
article
|
Journal description